MEPERIDINE HYDROCHLORIDE INJECTION USP SOLUTION

Страна: Канада

мова: англійська

Джерело: Health Canada

Активний інгредієнт:

MEPERIDINE HYDROCHLORIDE

Доступна з:

ICU MEDICAL CANADA INC

Код атс:

N02AB02

ІПН (Міжнародна Ім'я):

PETHIDINE

Дозування:

10MG

Фармацевтична форма:

SOLUTION

Склад:

MEPERIDINE HYDROCHLORIDE 10MG

Адміністрація маршрут:

INTRAVENOUS

Одиниць в упаковці:

30ML

Тип рецепту:

Narcotic (CDSA I)

Терапевтична области:

OPIATE AGONISTS

Огляд продуктів:

Active ingredient group (AIG) number: 0104542003; AHFS:

Статус Авторизація:

CANCELLED POST MARKET

Дата Авторизація:

2018-09-28

Характеристики продукта

_N_
_MEPERIDINE HYDROCHLORIDE INJECTION USP _
_Page 1 of 32 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
N
MEPERIDINE HYDROCHLORIDE INJECTION USP
10 mg/mL
Sterile Solution
OPIOID ANALGESIC
ICU Medical Canada Inc.
2600 Alfred-Nobel boul., suite 100
Saint-Laurent, QC
H4S 0A9
Date of Revision:
July 31, 2018
Submission Control No: 212494
_N_
_MEPERIDINE HYDROCHLORIDE INJECTION USP _
_Page 2 of 32 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
..................................................................................................13
DRUG INTERACTIONS
..................................................................................................15
DOSAGE AND ADMINISTRATION
..............................................................................16
OVERDOSAGE
................................................................................................................21
ACTION AND CLINICAL PHARMACOLOGY
............................................................21
STORAGE AND STABILITY
..........................................................................................23
SPECIAL HANDLING INSTRUCTIONS
.......................................................................23
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................23
PART II: SCIENTIFIC INFORMATION
...............................................................................24
PHARMACEUTICAL INFORMATION
...............................................................